Ligand Pharmaceuticals Incorporated Share Price Today: Live Updates & Key Insights
Ligand Pharmaceuticals Incorporated share price today is $204.75, up -2.7%. The stock opened at $211.41 against the previous close of $210.49, with an intraday high of $212.84 and low of $204.655.
Ligand Pharmaceuticals Incorporated Share Price Chart
Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated Share Price Performance
Ligand Pharmaceuticals Incorporated Institutional Holdings
Ligand Pharmaceuticals Incorporated Market Status
Ligand Pharmaceuticals Incorporated Fundamentals
Market Cap 4084.14 M
PB Ratio 4.015
PE Ratio 33.4657
Enterprise Value 3779.32 M
Total Assets 1560.64 M
Volume 468277
Ligand Pharmaceuticals Incorporated Company Financials
About Ligand Pharmaceuticals Incorporated & investment objective
Company Information Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
Organisation Biotechnology
Employees 47
Industry Biotechnology
CEO Mr. Todd C. Davis Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Ligand Pharmaceuticals Incorporated FAQs
What is the share price of Ligand Pharmaceuticals Incorporated today?
The current share price of Ligand Pharmaceuticals Incorporated is $204.75.
Can I buy Ligand Pharmaceuticals Incorporated shares in India?
Yes, Indian investors can buy Ligand Pharmaceuticals Incorporated shares by opening an international trading and demat account with Motilal Oswal.
How to buy Ligand Pharmaceuticals Incorporated shares in India?
You can easily invest in Ligand Pharmaceuticals Incorporated shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Ligand Pharmaceuticals Incorporated shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Ligand Pharmaceuticals Incorporated.
Can I buy fractional shares of Ligand Pharmaceuticals Incorporated?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated has a market cap of $4084.14 M.
In which sector does Ligand Pharmaceuticals Incorporated belong?
Ligand Pharmaceuticals Incorporated operates in the Biotechnology sector.
What documents are required to invest in Ligand Pharmaceuticals Incorporated stocks?
To invest, you typically need:
What is the PE and PB ratio of Ligand Pharmaceuticals Incorporated?
The PE ratio of Ligand Pharmaceuticals Incorporated is 33.47 and the PB ratio is 4.02.